Salpingectomy During Cesarean Section

Not Applicable

• Conditions: Healthy
• Interventions: Procedure: salpingectomy group I; Procedure: tubal ligation group II

• Registration Number: NCT02880423
• Lead Sponsor: Bnai Zion Medical Center

Brief Summary

Based on the accumulated literature, salpingectomy may significantly reduce the risk for ovarian cancer. If investigators can prove that there is no increase in surgical complications and morbidity during salpingectomy in CS, compared to tubal ligation, investigators can recommend for women who are interested in sterilization- salpingectomy during cesarean section .

Detailed Description

Until recently, ovarian resection was considered the only option to prevent ovarian cancer. Recently new evidence showing that the fallopian tube itself may be the source of certain types of ovarian cancer. So salpingectomy, may offer some protection. However, the extent of this protection has not been determined. Therefore, and based on the foregoing, the investigators think there is an advantage in removal of fallopian tubes rather than tubal ligation Cesarean sections. Given the lack of evidence in the literature about the complications of this procedure, currently the investigators organize a study examines the rate of complications of salpingectomy compared to tubal ligation during cesarean section.

Therefore, the main objective of the study is to assess the incidence of intra-operative complications during cesarean section.

The effect of the procedure will be examined on the following indicators:

1. The duration of the operation,

2. The rates of bleeding during the operation as estimated by the surgeon,

3. hemoglobin before and after the surgery,

4. Rates of giving blood or after surgery

5. The technical difficulty in performing tubal resection according to surgeon assessment

6. The need for further surgical intervention

A secondary objective of the study is evaluating the long-term complications:

1. Assessment of pain intensity at three months after surgery

2. Evaluation of menopausal symptoms, three months after surgery

3. Test ovarian sonar and Doppler three months after surgery

4. Testing the value of AMH three months after surgery

Study Timeline

• Study First Submitted: 2016-07-29
• Status Verified: 2016-08
• Study First Submitted QC: 2016-08-25
• Last Update Submitted: 2016-08-25
• Study First Posted: 2016-08-26
• Last Update Posted: 2016-08-26
• Study Start: 2016-09
• Primary Completion: 2018-07
• Study Completion: 2018-07

Recruitment & Eligibility

• Status: UNKNOWN
• Sex: Female
• Target Recruitment: 100

Inclusion Criteria

• Women planned for cesarean section , according to medical or obstetric indication , and seek sterilization
• Women aged 30 and older
• Women who are capable to understand , read and sign an informed consent form

Exclusion Criteria

• women aged less then 30 years
• women who disagree to participate in the research

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Arm && Interventions

Group	Intervention	Description
salpingectomy group I	salpingectomy group I	salpingectomy during cesarean section for sterilization
tubal ligation group II	tubal ligation group II	tubal ligation in cesarean section

Primary Outcome Measures

Name	Time	Method
intra- operative complications	5 days	operation duration,hemorrhage, technical difficulty in performing salpingectomy during CS

Secondary Outcome Measures

Name	Time	Method
long term complication	3 months	pain after surgery, signs and symptoms of menopause, reduced ovarian reserve by AMH test

Trial Locations

Locations (1)

ISRAEL; 🇮🇱 Haifa, Israel